Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros










Intervalo de año de publicación
1.
AIDS Care ; : 1-11, 2024 Apr 22.
Artículo en Inglés | MEDLINE | ID: mdl-38648527

RESUMEN

Despite success in achieving viral suppression during pregnancy in people living with HIV (PLWH), postpartum adherence remains a challenge. We aimed to describe rates of adherence at a Prevention of Mother-to-Child HIV Transmission (PMTCT) Center before and during the COVID-19 pandemic. This study was conducted from a cohort of PLWH who received prenatal care and were virally suppressed near delivery. We tracked combined antiretroviral therapy (cART) pickups for 12 months and HIV viral load (VL) from 2 to 12 months after delivery. We defined flexible adherence as a monthly pickup of cART and strict adherence as also having VL < 200 copies/mL and at least one maternal HIV VL between two and twelve months postpartum. Pre-pandemic was defined as delivery from March 2017-February 2019 and pandemic as March 2020-February 2022. During the study, 1119 PLWH were followed, and 965 (86%) were suppressed near delivery. There were 511 pre-pandemic and 290 pandemic participants. Adherence rates were 66/511 (13%) and 38/290 (13%), respectively. During the pandemic, more participants conceived using cART and were undetectable at the start of prenatal care; nevertheless, postpartum adherence was no better than pre-pandemic underscoring the need to improve strategies for adherence specific to this subset of PLWH in the postpartum period.

2.
J Bras Pneumol ; 46(1): e20190006, 2020.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-31859815

RESUMEN

OBJECTIVE: To estimate the prevalence of respiratory symptoms and asthma, according to body mass index (BMI), as well as to evaluate factors associated with physician-diagnosed asthma, in individuals ≥ 40 years of age. METHODS: This was a population-based cross-sectional study conducted in Florianópolis, Brazil, with probability sampling. Data were collected during home visits. Demographic data were collected, as were reports of physician-diagnosed asthma, respiratory symptoms, medications in use, and comorbidities. Anthropometric measurements were taken. Individuals also underwent spirometry before and after bronchodilator administration. Individuals were categorized as being of normal weight (BMI < 25 kg/m2), overweight (25 kg/m2 ≥ BMI < 30 kg/m2), or obese (BMI ≥ 30 kg/m2). RESULTS: A total of 1,026 individuals were evaluated, 274 (26.7%) were of normal weight, 436 (42.5%) were overweight, and 316 (30.8%) were obese. The prevalence of physician-diagnosed asthma was 11.0%. The prevalence of obesity was higher in women (p = 0.03), as it was in respondents with ≤ 4 years of schooling (p < 0.001) or a family income of 3-10 times the national minimum wage. Physician-diagnosed asthma was more common among obese individuals than among those who were overweight and those of normal weight (16.1%, 9.9%, and 8.0%, respectively; p = 0.04), as were dyspnea (35.5%, 22.5%, and 17.9%, respectively; p < 0.001) and wheezing in the last year (25.6%, 11.9%, and 14.6%, respectively; p < 0.001). These results were independent of patient smoking status. In addition, obese individuals were three times more likely to report physician-diagnosed asthma than were those of normal weight (p = 0.005). CONCLUSIONS: A report of physician-diagnosed asthma showed a significant association with being ≥ 40 years of age and with having a BMI ≥ 30 kg/m2. Being obese tripled the chance of physician-diagnosed asthma.


Asunto(s)
Asma/diagnóstico , Asma/etiología , Obesidad/complicaciones , Adulto , Asma/epidemiología , Índice de Masa Corporal , Brasil/epidemiología , Broncodilatadores/administración & dosificación , Tos/diagnóstico , Tos/epidemiología , Estudios Transversales , Disnea/diagnóstico , Disnea/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Prevalencia , Ruidos Respiratorios/diagnóstico , Factores Socioeconómicos , Espirometría
3.
J. bras. pneumol ; 46(1): e20190006, 2020. tab, graf
Artículo en Inglés | LILACS | ID: biblio-1056620

RESUMEN

ABSTRACT Objective: To estimate the prevalence of respiratory symptoms and asthma, according to body mass index (BMI), as well as to evaluate factors associated with physician-diagnosed asthma, in individuals ≥ 40 years of age. Methods: This was a population-based cross-sectional study conducted in Florianópolis, Brazil, with probability sampling. Data were collected during home visits. Demographic data were collected, as were reports of physician-diagnosed asthma, respiratory symptoms, medications in use, and comorbidities. Anthropometric measurements were taken. Individuals also underwent spirometry before and after bronchodilator administration. Individuals were categorized as being of normal weight (BMI < 25 kg/m2), overweight (25 kg/m2 ≥ BMI < 30 kg/m2), or obese (BMI ≥ 30 kg/m2). Results: A total of 1,026 individuals were evaluated, 274 (26.7%) were of normal weight, 436 (42.5%) were overweight, and 316 (30.8%) were obese. The prevalence of physician-diagnosed asthma was 11.0%. The prevalence of obesity was higher in women (p = 0.03), as it was in respondents with ≤ 4 years of schooling (p < 0.001) or a family income of 3-10 times the national minimum wage. Physician-diagnosed asthma was more common among obese individuals than among those who were overweight and those of normal weight (16.1%, 9.9%, and 8.0%, respectively; p = 0.04), as were dyspnea (35.5%, 22.5%, and 17.9%, respectively; p < 0.001) and wheezing in the last year (25.6%, 11.9%, and 14.6%, respectively; p < 0.001). These results were independent of patient smoking status. In addition, obese individuals were three times more likely to report physician-diagnosed asthma than were those of normal weight (p = 0.005). Conclusions: A report of physician-diagnosed asthma showed a significant association with being ≥ 40 years of age and with having a BMI ≥ 30 kg/m2. Being obese tripled the chance of physician-diagnosed asthma.


RESUMO Objetivo: Estimar a prevalência de sintomas respiratórios e asma de acordo com o índice de massa corpórea (IMC) em indivíduos com idade ≥ 40 anos e avaliar os fatores associados ao relato de diagnóstico médico de asma. Métodos: Estudo transversal de base populacional realizado no município de Florianópolis (SC), com coleta domiciliar de dados e processo de amostragem probabilístico. Foram coletadas informações demográficas, assim como sobre relato de diagnóstico médico de asma, sintomas respiratórios, medicações em uso e comorbidades. Também foram realizadas medidas antropométricas e espirometria pré- e pós-broncodilatador. O IMC foi categorizado em normal (IMC < 25 kg/m2), sobrepeso (25 kg/m2 ≥ IMC < 30 kg/m2) e obesidade (IMC ≥ 30 kg/m2). Resultados: Foram avaliados 1.026 indivíduos, 274 (26,7%) com IMC normal, 436 (42,5%) com sobrepeso e 316 (30,8%) obesos. A prevalência de diagnóstico médico de asma foi de 11,0%. A prevalência de obesidade foi maior em mulheres (p = 0,03) e em entrevistados com escolaridade < 4 anos (p < 0,001) ou com renda familiar entre 3-10 salários mínimos. Obesos, quando comparados com aqueles com sobrepeso e peso normal, relataram mais frequentemente diagnóstico médico de asma (16,1%, 9,9% e 8,0%, respectivamente; p = 0,04), dispneia (35,5%, 22,5% e 17,9%, respectivamente; p < 0,001) e sibilos no último ano (25,6%, 11,9% e 14,6%, respectivamente; p < 0,001). Esses resultados foram independentes do status tabágico. Além disso, obesos tinham uma chance três vezes maior de relato de diagnóstico médico de asma do que não obesos (p = 0,005). Conclusões: Houve associação significativa entre o relato de diagnóstico médico de asma em indivíduos com idade ≥ 40 anos e IMC ≥ 30 kg/m2. Ser obeso triplicou a chance de diagnóstico médico de asma.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Asma/diagnóstico , Asma/etiología , Obesidad/complicaciones , Factores Socioeconómicos , Espirometría , Brasil/epidemiología , Broncodilatadores/administración & dosificación , Índice de Masa Corporal , Ruidos Respiratorios/diagnóstico , Prevalencia , Tos/diagnóstico , Tos/epidemiología , Disnea/diagnóstico , Disnea/epidemiología , Obesidad/epidemiología
4.
Artículo en Portugués | LILACS, Index Psicología - Revistas | ID: biblio-910896

RESUMEN

Este estudo dedicou-se a investigar e compreender as percepções de jovens operários do setor informal calçadista sobre o trabalho. Participaram do estudo cinco jovens, com idade entre 16 e 24 anos, trabalhadores de bancas calçadistas localizadas em um bairro tipicamente operário de uma cidade do interior do estado de São Paulo. Para isso, utilizou-se a carto(foto)grafia como um dos métodos investigativos. Os próprios participantes produziram fotografias de cenas acerca do seu trabalho e falaram sobre seus significados por meio das entrevistas individual e de grupo focal, que foram gravadas em áudio e literalmente transcritas. A avaliação dos dados foi orientada pelos princípios da categorização da análise de conteúdo, e a entrevista em grupo focal foi analisada a partir de categorias formadas e nomeadas pelos próprios participantes e discutida à luz do referencial teórico-conceitual adotado. Concluiu-se então que a maioria dos participantes vive em um universo com possibilidades cristalizadas, o que os impossibilita de construir novos modos de ser e existir no mundo, alojados na alienada lógica dominante, aprisionados à subjetividade capitalística. Alguns, ainda, mesmo que sutilmente, conseguem ver novas possibilidades e tecer algum desejo de transformação


This study aimed to investigate and understand the meanings attributed to work by young workers in the informal footwear sector. Five students between the ages of 16 and 24 participated in this study, all of them were workers of small footwear industries located in a typical working-class district of a city in the state of São Paulo. The carto(photo)graphy was one of the investigative methods used. The participants themselves took photographs of scenes involving their work and talked about their meanings through individual and focus group interviews that were audio-recorded and transcribed verbatim. The data evaluation was done by a traditional content analysis, and the focus group interview was analyzed from categories formed and named by the participants themselves and discussed according to the chosen theoretical-conceptual framework. It was therefore concluded that most of the participants live in a universe with very limited possibilities, what makes it impossible for them to build new ways of being and existing in the world, living inside the alienating dominant logic, trapped in the capitalistic subjectivity. Some, though, even subtly, can see new possibilities and have a desire for transformation


Asunto(s)
Humanos , Masculino , Adolescente , Adulto Joven , Sector Informal , Percepción Social , Grupos Profesionales/psicología , Grupos Focales , Desarrollo Humano
5.
Rev. bras. reumatol ; 52(3): 442-446, maio-jun. 2012. ilus
Artículo en Portugués | LILACS | ID: lil-624879

RESUMEN

Calcificação e ossificação do ligamento amarelo ou do ligamento longitudinal posterior são causas de mielopatia compressiva, mais frequentes nos níveis torácicos inferiores e bastante raras em populações ocidentais. A descompressão cirúrgica é a única terapia proposta, mas a doença costuma ser progressiva e sua recorrência após a cirurgia não é incomum. Mediadores inflamatórios podem ter algum papel na progressão da mielopatia compressiva, mas não se tem notícia de qualquer proposta de abordagem terapêutica envolvendo agentes anti-inflamatórios. Neste contexto, relatamos um caso de mielopatia compressiva por calcificação do ligamento amarelo em que se observou hiperproteinorraquia e resposta à corticoterapia. Tais informações são inéditas e podem fornecer novas ideias para a compreensão da doença.


Calcification and ossification of the ligamentum flavum or of the posterior longitudinal ligament are causes of compressive myelopathy, more frequent in the lower thoracic levels, and extremely rare in Western populations. Surgical decompression is the only therapy, but the disease is usually progressive, and its recurrence after surgery is common. Inflammatory mediators might play a role in the progression of compressive myelopathy, but, to our knowledge, the therapeutic approach involving anti-inflammatory agents has never been tried before. We report a case of compressive myelopathy due to calcification of the ligamentum flavum, in which hyperproteinorachia and response to steroid therapy have been observed. Those data have not been published before and might provide new ideas for the disease understanding.


Asunto(s)
Femenino , Humanos , Persona de Mediana Edad , Calcinosis/complicaciones , Glucocorticoides/uso terapéutico , Ligamento Amarillo , Metilprednisolona/uso terapéutico , Enfermedades de la Médula Espinal/tratamiento farmacológico , Enfermedades de la Médula Espinal/etiología , Calcinosis/líquido cefalorraquídeo , Proteínas del Líquido Cefalorraquídeo/análisis , Enfermedades de la Médula Espinal/líquido cefalorraquídeo , Vértebras Torácicas
6.
Rev Bras Reumatol ; 52(3): 438-46, 2012.
Artículo en Inglés, Portugués | MEDLINE | ID: mdl-22641597

RESUMEN

Calcification and ossification of the ligamentum flavum or of the posterior longitudinal ligament are causes of compressive myelopathy, more frequent in the lower thoracic levels, and extremely rare in Western populations. Surgical decompression is the only therapy, but the disease is usually progressive, and its recurrence after surgery is common. Inflammatory mediators might play a role in the progression of compressive myelopathy, but, to our knowledge, the therapeutic approach involving anti-inflammatory agents has never been tried before. We report a case of compressive myelopathy due to calcification of the ligamentum flavum, in which hyperproteinorachia and response to steroid therapy have been observed. Those data have not been published before and might provide new ideas for the disease understanding.


Asunto(s)
Calcinosis/complicaciones , Glucocorticoides/uso terapéutico , Ligamento Amarillo , Metilprednisolona/uso terapéutico , Enfermedades de la Médula Espinal/tratamiento farmacológico , Enfermedades de la Médula Espinal/etiología , Calcinosis/líquido cefalorraquídeo , Proteínas del Líquido Cefalorraquídeo/análisis , Femenino , Humanos , Persona de Mediana Edad , Enfermedades de la Médula Espinal/líquido cefalorraquídeo , Vértebras Torácicas
7.
Expert Opin Ther Targets ; 15(9): 1099-112, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21702716

RESUMEN

INTRODUCTION: The mammalian target of rapamycin (mTOR) protein is a downstream effector of the phosphatidilinositol-3 kinase (PI3K)/Akt pathway, which regulates not only cell proliferation and viability, but also iodide uptake in thyroid cells. Genetic alterations in the PI3K/Akt/mTOR pathway are common during thyroid cancer progression, and thus, these proteins are attractive targets for cancer therapy. So far, specific mTOR inhibitors, such as rapamycin analogs, have been developed and studied as anti-cancer agents. AREAS COVERED: This review discusses evidence that justifies the potential use of mTOR signaling pathway inhibitors as therapeutic agents for thyroid cancer. EXPERT OPINION: In the near future, mTOR-targeted drugs might represent a new approach for the therapy of thyroid cancer patients; rapamycin analogs have already been developed and are currently being clinically tested. Besides the antiproliferative action of mTOR inhibition, the stimulatory effect on thyroid iodide uptake can also be useful in the treatment of recurrent thyroid cancer. Therefore, if rapamycin analogs are able to increase iodide uptake in thyroid cancer, either alone or in combination with other agents, this will represent a new approach for the treatment of thyroid cancer, which may possibly improve the treatment of patients in which radioiodine therapy is not effective.


Asunto(s)
Antineoplásicos/farmacología , Serina-Treonina Quinasas TOR/antagonistas & inhibidores , Neoplasias de la Tiroides/tratamiento farmacológico , Animales , Sistemas de Liberación de Medicamentos , Diseño de Fármacos , Humanos , Yoduros/metabolismo , Recurrencia Local de Neoplasia , Transducción de Señal/efectos de los fármacos , Sirolimus/análogos & derivados , Sirolimus/farmacología , Serina-Treonina Quinasas TOR/metabolismo , Neoplasias de la Tiroides/patología
8.
J Clin Endocrinol Metab ; 95(12): 5403-11, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20826581

RESUMEN

CONTEXT: Thyroperoxidase (TPO) and dual oxidase (DUOX) are present at the apical membrane of thyrocytes, where TPO catalyzes thyroid hormone biosynthesis in the presence of H2O2 produced by DUOX. Both enzymes are colocalized and associated, but the consequences of this interaction remain obscure. OBJECTIVE: The objective of this study was to evaluate the functional consequences of TPO-DUOX interaction at the plasma membrane. DESIGN: The functional consequences of DUOX-TPO interaction were studied by measuring extracellular H2O2 concentration and TPO activity in a heterologous system. For this purpose, HEK293 cells were transiently transfected with a combination of human TPO with human DUOX1 or DUOX2 in the presence of their respective maturation factors, DUOXA1 or DUOXA2. The effect of human DUOX2 mutants in which cysteine residues in the N-terminal domain were replaced by glycines was also analyzed. RESULTS: We observed that production of H2O2 decreases both TPO and DUOX activities. We show that TPO presents a catalase-like effect that protects DUOX from inhibition by H2O2. This catalase-like effect depends on the association between both enzymes, which probably occurs through the DUOX peroxidase-like domain because this effect was not observed with human DUOX2 mutants. CONCLUSION: The DUOX-TPO association at the plasma membrane is relevant for normal enzyme properties. Normally, TPO consumes H2O2 produced by DUOX, decreasing the availability of this substance at the apical membrane of thyrocytes and, in turn, probably decreasing the oxidative damage of macromolecules.


Asunto(s)
Autoantígenos/metabolismo , Membrana Celular/enzimología , Yoduro Peroxidasa/metabolismo , Proteínas de Unión a Hierro/metabolismo , NADPH Oxidasas/metabolismo , Oxidorreductasas/metabolismo , Autoantígenos/genética , Catalasa/metabolismo , Oxidasas Duales , Citometría de Flujo , Regulación Enzimológica de la Expresión Génica , Células HEK293 , Humanos , Peróxido de Hidrógeno/metabolismo , Yoduro Peroxidasa/genética , Proteínas de Unión a Hierro/genética , Riñón/enzimología , NADPH Oxidasas/genética , Oligonucleótidos Antisentido , Transfección
9.
J Endocrinol ; 206(1): 113-20, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20392814

RESUMEN

Phosphoinositide-3-kinase (PI3K) inhibition increases functional sodium iodide symporter (NIS) expression in both FRTL-5 rat thyroid cell line and papillary thyroid cancer lineages. In several cell types, the stimulation of PI3K results in downstream activation of the mechanistic target of rapamycin (MTOR), a serine-threonine protein kinase that is a critical regulator of cellular metabolism, growth, and proliferation. MTOR activation is involved in the regulation of thyrocyte proliferation by TSH. Here, we show that MTOR inhibition by rapamycin increases iodide uptake in TSH-stimulated PCCL3 thyroid cell line, although the effect of rapamycin was less pronounced than PI3K inhibition. Thus, NIS inhibitory pathways stimulated by PI3K might also involve the activation of proteins other than MTOR. Insulin downregulates iodide uptake and NIS protein expression even in the presence of TSH, and both effects are counterbalanced by MTOR inhibition. NIS protein expression levels were correlated with iodide uptake ability, except in cells treated with TSH in the absence of insulin, in which rapamycin significantly increased iodide uptake, while NIS protein levels remained unchanged. Rapamycin avoids the activation of both p70 S6 and AKT kinases by TSH, suggesting the involvement of MTORC1 and MTORC2 in TSH effect. A synthetic analog of rapamycin (everolimus), which is clinically used as an anticancer agent, was able to increase rat thyroid iodide uptake in vivo. In conclusion, we show that MTOR kinase participates in the control of thyroid iodide uptake, demonstrating that MTOR not only regulates cell survival, but also normal thyroid cell function both in vitro and in vivo.


Asunto(s)
Péptidos y Proteínas de Señalización Intracelular/fisiología , Proteínas Serina-Treonina Quinasas/fisiología , Yoduro de Sodio/metabolismo , Glándula Tiroides/metabolismo , Animales , Línea Celular , Supervivencia Celular/fisiología , Cromonas/farmacología , Insulina/farmacología , Péptidos y Proteínas de Señalización Intracelular/antagonistas & inhibidores , Radioisótopos de Yodo , Morfolinas/farmacología , Fosfatidilinositol 3-Quinasas/fisiología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Fosforilación/efectos de los fármacos , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Proteínas Quinasas S6 Ribosómicas 70-kDa/metabolismo , Sirolimus/farmacología , Simportadores/análisis , Simportadores/antagonistas & inhibidores , Simportadores/fisiología , Serina-Treonina Quinasas TOR , Glándula Tiroides/química , Glándula Tiroides/citología , Glándula Tiroides/efectos de los fármacos , Tirotropina/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...